Risk of Pancreatitis With Incretin Therapies Versus Thiazolidinediones in the Veterans Health Administration

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

(2021) Suetonia C Palmer et al.   BMJ-British Medical Journal

Sex-Related Differences of Acute and Chronic Pancreatitis in Adults

(2021) Madeline Drake et al.   Journal of Clinical Medicine

Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes

(2021) Anand-Krishna Singh et al.   Pharmaceuticals

Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis

(2021) Jordan P. Iannuzzi et al.   GASTROENTEROLOGY

The protective role of DPP4 inhibitors in atherosclerosis

(2020) Hengdao Liu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Thiazolidinediones: the Forgotten Diabetes Medications

(2019) Harold E. Lebovitz   Current Diabetes Reports

An overview of GLP-1 agonists and recent cardiovascular outcomes trials

(2019) Kelsey H Sheahan et al.   POSTGRADUATE MEDICAL JOURNAL

The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults

(2018) Jin-Liern Hong et al.   DIABETES CARE

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

(2018) Patrick M O'Neil et al.   LANCET

GLP-1 receptor agonists and cardiovascular outcome trials: An update

(2018) Eirini Andrikou et al.   Hellenic Journal of Cardiology

Association between dipeptidyl peptidase-4 inhibitor drugs and risk of acute pancreatitis

(2017) Shimin Chen et al.   MEDICINE

Infection increases mortality in necrotizing pancreatitis: A systematic review and meta-analysis

(2016) Mikkel Werge et al.   PANCREATOLOGY

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis

(2016) Laurent Azoulay et al.   JAMA Internal Medicine

Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan

(2015) Chin-Hsiao Tseng   ANNALS OF MEDICINE

Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database

(2015) Davide Soranna et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

A systematic review of acute pancreatitis as an adverse event of type 2 diabetes drugs: from hard facts to a balanced position

(2014) C. B. Giorda et al.   DIABETES OBESITY & METABOLISM

Risk of pancreatitis in patients treated with incretin-based therapies

(2014) Juris J. Meier et al.   DIABETOLOGIA

American College of Gastroenterology Guideline: Management of Acute Pancreatitis

(2013) Scott Tenner et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A pooled analysis of exenatide use and risk of acute pancreatitis

(2013) David D. Dore et al.   CURRENT MEDICAL RESEARCH AND OPINION

Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus

(2013) Sonal Singh et al.   JAMA Internal Medicine

Drug induced pancreatitis

(2010) Claudia J. Nitsche et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Acute pancreatitis: Etiology and common pathogenesis

(2009) Guo-Jun Wang et al.   WORLD JOURNAL OF GASTROENTEROLOGY